St Ec 9004 Blood Chemistry Analyzer with Blood Coagulation Function

Name: St Ec 9004 Blood Chemistry Analyzer with Blood Coagulation Function
Brand: Somatech Medical Co., Ltd.
SKU: 2215454965

Sichuan, ChinaSomatech Medical Co., Ltd.

US$199.00-999.00

1 Piece

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Biochemistry Analyzer

Model NO.

ST EC 9004

Certification

CE, FDA, EEC, MSDS, ISO13485

Group

Specific Population

Warranty

1 Year

After-Sale Service

Online Technical Support

Product Name

Blood Chemistry Equipment and Coagulation Analyzer

Test Method

1 Point End, 2 Point End, Kinetics, Fixed-Time, Tu

Optics

8 Standard Wavelengths

Resolution

0.0001 ABS

Display

7.0" TFT LCD with Touch Screen

Transport Package

Standard Package

Specification

400*300* 200mm(L *W*H)

Trademark

Soma Tech

Origin

Mianyang City Sichuan Province

Production Capacity

1200/Year

Company profile

Importers and ExportersODM ServicesManagement CertificationQuality Assurance

Somatech Medical Co., Ltd.

Sichuan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 10 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.78h

AI-Powered supplier vetting

SummaryThe supplier produces, sells, and services Class II 6823 medical ultrasound instruments and related equipment, with additional mechanical and electronic product activities. It demonstrates broad customization, ODM availability, SDK support, recent new-product activity, raw-material traceability, 100% finished-product inspection, and documented corrective-action and complaint-handling procedures. Manufacturing includes three production lines and inventory capability, but the supplier lacks a valid manufacturing contract with related subcontractors, has no overseas agents, branches, warehouse, or showroom, and reports no overseas-service countries. Certification details are insufficiently specific, financial credibility cannot be assessed from the provided information, and no evidence of cooperation with major brands or Fortune 500 companies is provided.

Supplier typeThe supplier’s stated business scope covers production, sales, and services for Class II 6823 medical ultrasound instruments and related equipment, along with mechanical and electronic products and import/export activities. This supports classification as a medical ultrasound equipment manufacturer and service supplier.

After-Sales capabilityThe supplier has documented procedures and records for corrective and preventive actions and customer complaints, offers inventory capability, and has participated in Arab Health 2025. However, it has no overseas agents or branches, overseas warehouse, overseas showroom, or stated overseas-service countries, limiting the evidence for broad international after-sales coverage.

R&D capabilityThe supplier reports new products during the past year, ODM services, an available SDK, four R&D engineers, and one national science and technology progress award. These explicit indicators support active R&D and product-development capability.

Production capacityProduction evidence includes three production lines, four quality inspectors, 100% finished-product inspection, quality assurance, and inventory capability. However, the supplier lacks a valid manufacturing contract with related subcontractors, does not continuously reconcile production quantities for each batch, and has no outsourcing SOP, creating documented production-control weaknesses.

Customization capabilityThe supplier explicitly provides customization from samples, customization from designs, full customization, and minor customization, and also offers ODM services. The repeated evidence indicates broad customization coverage.

Client casesThe supplier reports no cooperation with Fortune 500 companies and no OEM service for popular brands. Although repeat-buyer preference is stated at 50%–80%, no identifiable customer names or documented customer cases are provided.